Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 1247191, 8 pages
http://dx.doi.org/10.1155/2016/1247191
Research Article

Protective Effects of Caffeic Acid Phenethyl Ester on Fluoxetine-Induced Hepatotoxicity: An Experimental Study

1Department of Family Physicians, Faculty of Medicine, Dicle University, 21280 Diyarbakir, Turkey
2Department of Immunology, Faculty of Medicine, Dicle University, 21280 Diyarbakir, Turkey
3Department of Physiology, Faculty of Medicine, Zirve University, 27260 Gaziantep, Turkey
4Department of Biochemistry, Faculty of Medicine, Dicle University, 21280 Diyarbakir, Turkey
5Department of Pediatric Surgery, Faculty of Medicine, Dicle University, 21280 Diyarbakir, Turkey
6Department of Pathology, Faculty of Medicine, Dicle University, 21280 Diyarbakir, Turkey

Received 14 January 2016; Revised 9 March 2016; Accepted 27 March 2016

Academic Editor: Kazim Husain

Copyright © 2016 Ahmet Yılmaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Wernicke, “Safety and side effect profile of fluoxetine,” Expert Opinion on Drug Safety, vol. 3, no. 5, pp. 495–504, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. J. Garlow, B. Kinkead, M. E. Thase et al., “Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder,” Journal of Psychiatric Research, vol. 47, no. 9, pp. 1199–1203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. F. L. Cantrell, C. Vance, B. Schaber, and I. McIntyre, “Fatal fluoxetine intoxication with markedly elevated central blood, vitreous, and liver concentrations,” Journal of Analytical Toxicology, vol. 33, no. 1, pp. 62–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Rubino, N. Roskell, P. Tennis, D. Mines, S. Weich, and E. Andrews, “Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study,” British Medical Journal, vol. 334, no. 7587, pp. 242–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Lançon, D. Bernard, and T. Bougerol, “Fluoxetine, akathisia and suicide,” Encephale, vol. 23, no. 3, pp. 218–223, 1997. View at Google Scholar · View at Scopus
  6. T. Ayaz, Ö. Bilir, G. Ersunan et al., “Evaluation of drug intoxications due to suicides,” Konuralp Tip Dergisi, vol. 7, no. 1, pp. 53–56, 2015. View at Google Scholar
  7. L. Mielniczuk, R. A. DeKemp, C. Dennie et al., “Images in cardiovascular medicine. Fluorine-18-labeled deoxyglucose positron emission tomography in the diagnosis and management of aortitis with pulmonary artery involvement,” Circulation, vol. 111, no. 22, pp. e375–e376, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Brambilla, A. Cipriani, M. Hotopf, and C. Barbui, “Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data,” Pharmacopsychiatry, vol. 38, no. 2, pp. 69–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Özden, K. Bildirici, D. Üstüner et al., “Histopathologic examination of rat liver after experimental application of fluoxetine,” Türkiye Ekopatoloji Dergisi, vol. 11, no. 1, pp. 9–15, 2005. View at Google Scholar
  10. I. Inkielewicz-Stêpniak, “Impact of fluoxetine on liver damage in rats,” Pharmacological Reports, vol. 63, no. 2, pp. 441–447, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Zlatković, N. Todorović, N. Tomanović et al., “Chronic administration of fluoxetine or clozapine induces oxidative stress in rat liver: a histopathological study,” European Journal of Pharmaceutical Sciences, vol. 59, pp. 20–30, 2014. View at Publisher · View at Google Scholar
  12. E. Kılıç, A. Türkoğlu, A. Keleş, A. Ekinci, S. Kesgin, and M. Gümüş, “The antioxidant effects of pomegranate extract on local and remote organs in a mesenteric ischemia and reperfusion model,” Redox Report, 2015. View at Publisher · View at Google Scholar
  13. M. Gümüş, H. Yüksel, O. Evliyaoǧlu et al., “Effects of ellagic acid on copper, zinc, and biochemical values in serum and liver of experimental cholestatic rats,” Biological Trace Element Research, vol. 143, no. 1, pp. 386–393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Viuda-Martos, Y. Ruiz-Navajas, J. Fernández-López, and J. A. Pérez-Álvarez, “Functional properties of honey, propolis, and royal jelly,” Journal of Food Science, vol. 73, no. 9, pp. R117–R124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Çakir, E. Özkan, E. Dulundu et al., “Caffeic acid phenethyl ester (CAPE) prevents methotrexate-induced hepatorenal oxidative injury in rats,” Journal of Pharmacy and Pharmacology, vol. 63, no. 12, pp. 1566–1571, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Armutcu, S. Akyol, S. Ustunsoy, and F. F. Turan, “Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects (Review),” Experimental and Therapeutic Medicine, vol. 9, no. 5, pp. 1582–1588, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Gunduz, C. Biray, B. Kosova et al., “Evaluation of Manisa propolis effect on leukemia cell line by telomerase activity,” Leukemia Research, vol. 29, no. 11, pp. 1343–1346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Mohammadzadeh, M. Sharriatpanahi, M. Hamedi, Y. Amanzadeh, S. E. Sadat Ebrahimi, and S. N. Ostad, “Antioxidant power of Iranian propolis extract,” Food Chemistry, vol. 103, no. 3, pp. 729–733, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Oguz, M. Kapan, I. Kaplan et al., “The effects of sulforaphane on the liver and remote organ damage in hepatic ischemia-reperfusion model formed with pringle maneuver in rats,” International Journal of Surgery, vol. 18, pp. 163–168, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Şahin, S. Kaya, G. Türkcü et al., “The effects of caffeic acid phenethyl ester in acute methanol toxicity on rat retina and optic nerve,” Cutaneous and Ocular Toxicology, vol. 32, no. 4, pp. 263–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. R. K. Kuester, M. P. Waalkes, P. L. Goering, B. L. Fisher, R. S. McCuskey, and I. G. Sipes, “Differential hepatotoxicity induced by cadmium in fischer 344 and Sprague-Dawley rats,” Toxicological Sciences, vol. 65, no. 1, pp. 151–159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Erel, “A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation,” Clinical Biochemistry, vol. 37, no. 4, pp. 277–285, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Innocenti and C. T. Supuran, “Paraoxon, 4-nitrophenyl phosphate and acetate are substrates of alpha- but not of beta-, gamma- and zeta-carbonic anhydrases,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 21, pp. 6208–6212, 2010. View at Google Scholar
  24. F. Gil, M. C. Gonzalvo, A. F. Hernandez, E. Villanueva, and A. Pla, “Differences in the kinetic properties, effect of calcium and sensitivity to inhibitors of paraoxon hydrolase activity in rat plasma and microsomal fraction from rat liver,” Biochemical Pharmacology, vol. 48, no. 8, pp. 1559–1568, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–1111, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. A. Camargo Jr., J. F. Madden, W. Gao, R. S. Selvan, and P.-A. Clavien, “Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent,” Hepatology, vol. 26, no. 6, pp. 1513–1520, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Feldman, L. Friedman, and L. J. Brandt, “Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology,” in Diagnosis, Managemen, p. 1575, Saunders Elsevier, Philadelphia, Pa, USA, 8th edition, 2006. View at Google Scholar
  28. J. Ezhilan, M. S. Juneja, T. George et al., “Prevention of no flow/slow reflow phenomenon in primary PCI by nicorandil,” Indian Heart Journal, vol. 59, no. 3, pp. 246–249, 2007. View at Google Scholar · View at Scopus
  29. A. P. Chew, W. S. Lim, and K. T. Tan, “Donepezil-induced hepatotoxicity in an elderly adult taking fluoxetine,” Journal of the American Geriatrics Society, vol. 62, no. 10, pp. 2009–2011, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Castiella and J. I. Arenas, “Fluoxetine hepatotoxicity,” American Journal of Gastroenterology, vol. 89, no. 3, pp. 458–459, 1994. View at Google Scholar · View at Scopus
  31. A. LLerena, P. Dorado, R. Berecz et al., “Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 783, no. 1, pp. 25–31, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. E. J. Souza, A. C. M. Polizello, S. A. Uyemura, O. Castro-Silva Jr., and C. Curti, “Effect of fluoxetine on rat liver mitochondria,” Biochemical Pharmacology, vol. 48, no. 3, pp. 535–541, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. H. F. Sakr, A. M. Abbas, A. Z. Elsamanoudy, and F. M. Ghoneim, “Effect of fluoxetine and resveratrol on testicular functions and oxidative stress in a rat model of chronic mild stress-induced depression,” Journal of Physiology and Pharmacology, vol. 66, no. 4, pp. 515–527, 2015. View at Google Scholar · View at Scopus
  34. J. A. Simplicio, L. B. Resstel, D. P. C. Tirapelli, P. D'Orléans-Juste, and C. R. Tirapelli, “Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment,” Vascular Pharmacology, vol. 73, pp. 124–137, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Chen, J. Zha, L. Yuan, and Z. Wang, “Effects of fluoxetine on behavior, antioxidant enzyme systems, and multixenobiotic resistance in the Asian clam Corbicula fluminea,” Chemosphere, vol. 119, pp. 856–862, 2015. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Uzar, A. Acar, O. Evliyaoǧlu et al., “The anti-oxidant and anti-apoptotic effects of nebivolol and zofenopril in a model of cerebral ischemia/reperfusion in rats,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 36, no. 1, pp. 22–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Cicek, R. Sutcu, O. Gokalp et al., “The effects of isoniazid on hippocampal NMDA receptors: protective role of erdosteine,” Molecular and Cellular Biochemistry, vol. 277, no. 1-2, pp. 131–135, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. D. Nguyen and D.-E. Sok, “Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action,” Free Radical Research, vol. 37, no. 12, pp. 1319–1330, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Uzar, H. Alp, M. U. Cevik et al., “Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats,” Neurological Sciences, vol. 33, no. 3, pp. 567–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. D. E. Johnston and D. E. Wheeler, “Chronic hepatitis related to use of fluoxetine,” The American Journal of Gastroenterology, vol. 92, no. 7, pp. 1225–1226, 1997. View at Google Scholar · View at Scopus
  41. Q. Cai, M. A. Benson, T. J. Talbot et al., “Acute hepatitis due to fluoxetine therapy,” Mayo Clinic Proceedings, vol. 74, no. 7, pp. 692–694, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Cosme, J. Barrio, C. Lobo, I. Gil, A. Castiella, and J. I. Arenas, “Acute cholestasis by fluoxetine,” The American Journal of Gastroenterology, vol. 91, no. 11, pp. 2449–2450, 1996. View at Google Scholar · View at Scopus